Indications and uses
Gradually fades areas of skin discoloration such as age spots freckles liver spots dark areas that can occur while using oral contraceptives.
Gradually fades areas of skin discoloration such as age spots freckles liver spots dark areas that can occur while using oral contraceptives.
If skin is sensitive, test on a small area inside the elbow overnight before use. Adults and children 12 years and older, apply a thin layer to affected area twice daily, or as directed by a doctor. If going outside, use a sunscreen or wear protective clothing. Children under 12 years of age, ask a doctor before use.
Hydroquinone, 2%; Octisalate, 3%
Gradually fades areas of skin discoloration such as
For external use only
consult a health professional before use.
water, glyceryl stearate, PEG-8, isopropyl myristate, isopropyl isostearate, cetyl alcohol, PEG-100 stearate, fragrance, citric acid, methylparaben, propylparaben, sodium bisulfite.
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 12022-015 | 12022-015-00 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| POLYETHYLENE GLYCOL 400 | B697894SGQ | IACT |
| ISOPROPYL MYRISTATE | 0RE8K4LNJS | IACT |
| ISOPROPYL ISOSTEARATE | C67IXB9Y7T | IACT |
| CETYL ALCOHOL | 936JST6JCN | IACT |
| PEG-100 STEARATE | YD01N1999R | IACT |
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| METHYLPARABEN | A2I8C7HI9T | IACT |
| PROPYLPARABEN | Z8IX2SC1OH | IACT |
| SODIUM BISULFITE | TZX5469Z6I | IACT |
| HYDROQUINONE | XV74C1N1AE | ACTIB |
| OCTISALATE | 4X49Y0596W | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b34c925f-dbd9-5030-e053-2a95a90a19ea | 31660fbf-cbc8-4ca5-96d9-376e2a4da94e | 2020-11-04 | Warnings | 31660fbf-cbc8-4ca5-96d9-376e2a4da94e |
Adverse event summaries are temporarily unavailable. Other product information remains available.